Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Numbing shots could ease mysterious belly pain

NCT ID NCT06121466

Symptom relief Sponsor: Oregon Health and Science University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether injecting lidocaine into the abdominal wall can reduce chronic pain caused by trapped nerves. Researchers will follow 45 adults for three months, measuring pain levels and any side effects. The goal is to see if this simple procedure can provide lasting relief for people with anterior cutaneous nerve entrapment syndrome.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lidocaine
What this could lead to
If it works, this could offer a simple, non-surgical option for people with chronic abdominal wall pain.
What could go wrong
This is a small, early-phase study with only 45 people and no placebo group, so results may not be conclusive. Lidocaine injections can cause pain, bruising, or rare allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Localized abdominal wall pain * Average daily pain (7-day recall) ≥ 3 on a scale of 0-10 * Suspected abdominal wall etiology for abdominal pain * Positive Carnett's sign or pain near an incisional site * 18 years of age or older Exclusion Criteria: * Suspected visceral etiology for the abdominal pain * Severe allergy to lidocaine * Unwillingness or inability to provide informed consent * Low probability of follow-up * Abdominal wall hernia noted at the point of pain * History of trigger point injections for abdominal pain * Bleeding disorder * Pregnancy, incarceration or decisionally impaired

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anterior cutaneous nerve entrapment syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anterior cutaneous nerve entrapment syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anterior cutaneous nerve entrapment syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • OHSU

    RECRUITING

    Portland, Oregon, 97239, United States

  • Oregon Health Sciences University

    RECRUITING

    Portland, Oregon, 97239, United States